AOD9604 Overview

AOD9604 is a modified fragment of human growth hormone (HGH) specifically developed to combat obesity and related metabolic issues. AOD9604 works by stimulating the breakdown of fat (lipolysis) and inhibiting the formation of new fat tissue (lipogenesis). Unlike traditional HGH, AOD9604 does not affect insulin levels or growth, making it a targeted peptide for fat loss. This peptide has gained attention in research for its potential benefits in fat reduction, without the adverse effects associated with other HGH-related treatments.

Product Details

• Sequence: H-Tyr-His-Gly-Phe-Met-Arg-D-Arg-Lys-Tyr-Ser-Val-Gly-Ser-Leu-Gln-OH
• Molecular Formula: C78H123N23O23S2
• Molecular Weight: 1815.08 g/mol
• CAS Number: 221231-10-3
• PubChem CID: 70685657

Research Highlights

1. Fat Loss and Lipid Metabolism: AOD9604 enhances fat burning and inhibits the formation of new fat cells, making it a promising peptide for weight management.
2. Safety and Tolerance: In clinical trials, AOD9604 has demonstrated good tolerance and safety, with no negative impact on insulin levels or blood sugar regulation.
3. Anti-Obesity Properties: It selectively stimulates fat breakdown, particularly targeting stubborn fat areas, without influencing muscle mass or organ growth.
4. Potential for Joint and Cartilage Repair: Emerging studies suggest that AOD9604 may also have positive effects on joint and cartilage repair due to its regenerative properties.